Novavax, COVID-19 and mRNA vaccine
Novavax Inc. closed $11.71 below its 52-week high ($23.86), which the company achieved on June 6th.
John Jacobs left Plymouth Meeting's Harmony Biosciences in 2023 after overseeing its IPO. Now, he's got another biotech firm ...
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Novavax occupies five sites in Montgomery County totaling about 370,000 square feet. Its footprint includes its headquarters ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Ruxandra Draghia-Akli, MD, PhD, will join the Company in ...
On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...
Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...